Victus Femtosecond Laser Platform Gets FDA 501(k) Clearance

Bausch + Lomb and Technolas Perfect Vision GmbH (TPV) received 501(k) clearance from the U.S. Food and Drug Administration (FDA) for the Victus Femtosecond Laser Platform, the first femtosecond laser capable of supporting cataract and corneal procedures on a single platform. The versatile system is designed to reportedly provide greater precision compared to manual cataract surgery techniques, potentially enhancing patient experience.Read more.